Robert Brennan used high-pressure techniques to sell worthless penny shares to unwitting investors, defrauding them of more than $300m.
Articles written by Dr Matthew Partridge
Ted Baker shares are a bargain – here’s how to play it
The sharp decline in Ted Baker shares looks excessive, say Matthew Partridge.
Betting on politics: who will face Trump in the US election
Matthew Partridge turns his attention across the Atlantic and takes a look at Democratic Party’s potential candidates for the US presidential election.
Philip Morris and Altria merger: Big Tobacco bulks up
Philip Morris and Altria have reunited. This could spark another round of consolidation in the embattled tobacco industry. Matthew Partridge reports.
Tesco cashes out of the mortgage business
Tesco Bank has left the mortgage market by selling its £3.7bn loan book. Its 23,000 customers will be moved to the Halifax, a subsidiary of Lloyds.
Great frauds in history: John Sadleir
John Sadleir’s multiple deceptions destroyed the Tipperary Joint Stock Bank, ruining its shareholders and forcing many into bankruptcy.
Merger frenzy in the pharmaceuticals business
The record deal between Bristol-Myers Squibb and Celgene moved closer this week. The pharmaceuticals sector is rapidly consolidating. Matthew Partridge reports.
Betting on politics: the odds on the date of a general election
Punters are betting that a general election in Britain will happen sooner rather than later. Matthew Partridge looks at the odds.
America’s opioid crisis triggers first corporate fine
An Oklahoma judge has ordered Johnson & Johnson to pay $572m – much less than expected – in the first trial involving a state seeking compensation for the public-health crisis spawned by opioid painkillers.
3D printing: a blueprint for the future of manufacturing
Five years ago, 3D printing was a bubble that burst. But now its time has finally come – and its successor technology, 4D printing, is on the horizon, says Matthew Partridge.
